David Thomson
Corporate Officer/Principal bij North Carolina Central University
Profiel
David Thomson is currently a Professor of Pharmaceutical Sciences at North Carolina Central University and a Vice President at Shire Human Genetic Therapies, Inc. He was previously the Chief Operating Officer at Precision BioSciences, Inc. from 2019 to 2021.
Thomson holds a doctorate degree from Yale University and the University of Toronto, and an undergraduate degree from the University of Strathclyde.
Actieve functies van David Thomson
| Bedrijven | Functie | Begin |
|---|---|---|
| North Carolina Central University | Corporate Officer/Principal | - |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Eerdere bekende functies van David Thomson
| Bedrijven | Functie | Einde |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Chief Operating Officer | 02-07-2021 |
Opleiding van David Thomson
| Yale University | Doctorate Degree |
| University of Toronto | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
